“…Autologous serum eye drops have been recommended for the treatment of several ocular surface disturbances, such as Sjögren's syndrome-related tear deficiency, non-Sjögren's tear deficiency associated with graft-versus-host disease, neurotrophic keratitis, persistent epithelial defects, superior limbic keratoconjunctivitis, as well as a supportive measure in ocular surface reconstruction (4) . Its utilization in Ophthalmology arose out of the need of finding lacrimal substitutes which, in addition to lubricating the ocular surface, were able to provide other components of tears that are reduced in ocular surface disease (5) .…”